MAP Pharmaceuticals, Inc. (MAPP) Reports Q4 Loss of 45c/Share; to Restate Interim Statements for First 3 Qtrs. of 2011

Go back to MAP Pharmaceuticals, Inc. (MAPP) Reports Q4 Loss of 45c/Share; to Restate Interim Statements for First 3 Qtrs. of 2011
MAP Pharmaceuticals, Inc. (NYSE: MAPP) Delayed: 28.11 --0 (-0%)
Previous Close $28.11    52 Week High $25.03 
Open $28.11    52 Week Low $11.11 
Day High $28.11    P/E N/A 
Day Low $28.11    EPS $-3.11 
Volume 48,893